Rashmi Saluja, chairman of Religare Enterprises (REL), refuted allegations of insider trading and receiving disproportionate salary amidst the ongoing battle with the Burman family over REL control. Saluja denied receiving communication regarding the Burman family’s open offer before selling shares. She clarified that her compensation, including ESOPs, was transparent and approved by shareholders. Addressing IRDAI’s rejection of ESOPs from Care Health Insurance, Saluja stated they were granted as an REL employee, not solely for her role at Care.